NICOLINI GABRIELLA

Cadamuro, F., Piazzoni, M., Borghi, I., Baeri, A., Fumagalli, A., Perillo, F., et al. (2026). 3D Bioprinted Glioblastoma Multiforme Models: How the Extracellular Matrix Glycosignature Influences Drug Response. ADVANCED FUNCTIONAL MATERIALS [10.1002/adfm.77772]. Dettaglio

Cavaletti, G., Canta, A., Chiorazzi, A., Ballarini, E., Rodriguez, V., Scuteri, A., et al. (2026). Protective effect of new histone deacetylase 6 inhibitors in a cisplatin-induced peripheral neurotoxicity murine model. PAIN REPORTS, 11(2) [10.1097/PR9.0000000000001395]. Dettaglio

Melgari, D., Calamaio, S., Frosio, A., Prevostini, R., Malacrida, A., Anastasia, L., et al. (2026). Electrophysiological mechanisms behind the differential cardiotoxicity of chemotherapeutic agents Bortezomib and Carfilzomib. FRONTIERS IN DRUG DISCOVERY, 6, 1-14 [10.3389/fddsv.2026.1774061]. Dettaglio

Fermi, S., Malacrida, A., Molteni, L., Miloso, M., Cavaletti, G., Nicolini, G. (2025). SARM1 modulation by HDAC6 inhibition as a neuroprotective strategy in chemotherapy-induced peripheral neuropathy. Intervento presentato a: NeuroMi 2025: Milan Center for Neuroscience, Milano, Italia. Dettaglio

Silva, C., Zuliani, V., Nicolini, G., Malacrida, A., Rivara, M. (2025). Recent advances in the discovery of ALKBH 1–8 inhibitors. EXPERT OPINION ON DRUG DISCOVERY, 20(12), 1639-1654 [10.1080/17460441.2025.2582541]. Dettaglio